Loading provider…
Loading provider…
Hematology & Oncology Physician in Madison, WI
NPI: 1538184825Primary Practice Location
UW HEALTH
1625 S State St, Belvidere, IL
Primary Employer
University of Wisconsin Medical Foundation, Inc
uwhealth.org
HQ Phone
Get MD Ryan's Phone Numberphone_androidMobile
Get MD Ryan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWI State Medical License
WI State Medical License
2009 - 2025
IL State Medical License
2006 - 2017
NC State Medical License
2002 - 2007

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Carver College of Medicine
medicine.uiowa.edu
Medical School
Until 2002
University of Chicago
Fellowship • Hematology and Medical Oncology
2006 - 2009
University of North Carolina Hospitals
Residency • Internal Medicine
2002 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 70 | 113 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 150 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 45 | 135 |
| 4 | 99238Hospital discharge day management, 30 minutes or less | 20 | 20 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 16 | 17 |
Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T.
Authors: Takeshi Yokoo, Ivan Pedrosa, Michael Jeng, Shreyas Vasanawala
Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
Authors: Michaela Liedtke, Shukaib Arslan, Ehab Atallah, Ilana Yurkiewicz, Rory Shallis, Mark Litzow
Journal: Blood Adv
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Vorinostat, OTHER: Laboratory Biomarker Analysis, DRUG: Cytarabine, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, DRUG: Idarubicin, DRUG: Daunorubicin Hydrochloride
Lead Sponsor: University of Wisconsin, Madison
Intervention / Treatment: PROCEDURE: FLT-PET scans
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Decitabine, DRUG: Cytarabine, OTHER: Observation, DRUG: Clofarabine, PROCEDURE: Allogeneic hematopoietic stem cell transplantation, DRUG: Daunorubicin